Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4
Version of Record online: 30 JUL 2013
© 2013 Japanese Cancer Association
Volume 104, Issue 10, pages 1295–1302, October 2013
How to Cite
(Cancer Sci 2013; 104: 1295–1302
- Issue online: 3 OCT 2013
- Version of Record online: 30 JUL 2013
- Accepted manuscript online: 2 JUL 2013 03:03AM EST
- Manuscript Accepted: 22 JUN 2013
- Manuscript Revised: 17 JUN 2013
- Manuscript Received: 4 DEC 2012
- Ministry of Health, Labour and Welfare
- Japan Society for the Promotion of Science. Grant Numbers: 22590356, 22790378, 23116510, 20670004
- Ministry of Education, Culture, Sports, Science and Technology. Grant Number: 221S0001
- Princess Takamatsu Cancer Research Foundation
- Smoking Research Foundation of Japan
|cas12221-sup-0001-FigS1.jpg||image/jpg||952K||Fig. S1. Involvement of LPCAT4 in the synthesis of PC(16:0/16:1) in DLD1 in vitro.|
|cas12221-sup-0002-FigS2.jpg||image/jpg||655K||Fig. S2. Immunohistochemical analysis of the expression of LPCAT4 in adenomatous polyp.|
Table S1. Clinicopathological profile of the cases on tissue microarray.
Table S2. Clinicopathological profile of polyps.
Table S3. Correlation of intensities generated using a mass microscope and immunohistochemical score.
Supplementary Methods. Including: LPCAT assay; immunohistochemistry; RNAi; and RT-PCR.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.